Moreover, the signaling pathways evoked by PPAR-α and its interaction with other receptors from this family, such as PPAR-γ, may enhance the chances of improving neuroprotection in AD and other neurodegenerative/neuropsychiatric disorders. This evidence concerns the gene PPARG and Alzheimer disease.